Ozempic and Wegovy among drugs on Medicare list getting price cuts

By Ike Swetlitz and Damian Garde | Bloomberg The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than $200 billion …

Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiations

CMS selects Ozempic, 14 other drugs for Medicare price negotiations

CMS has named 15 additional prescription drugs, including diabetes medication Ozempic, for price negotiations under the Inflation Reduction Act. This marks the second round of negotiations aimed at reducing drug costs for Medicare beneficiaries.  The …

Novo's Ozempic, Wegovy targeted for medicare price cuts

The U.S. plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that's expected to save the government more than $200 billion over a decade.  Novo's …

Ozempic, Wegovy among drugs subject to Medicare price controls

Dr. Alexandra Sowa joins 'Varney & Co.' to discuss weight-loss drugs becoming widely available and RFK Jr.'s push to ban pharmaceutical television ads and processed foods. Highly coveted weight-loss related diabetes drugs produced by Danish …

Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations

HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide

The US Department of Health and Human Services (HHS), through the Centers for Medicare and Medicaid Services (CMS), announced an additional 15 drugs covered under Medicare Part D for price negotiations in 2025, targeted for chronic conditions including …

Health care utilization and costs for older adults aging into Medicare after the affordable care act

About The Study: This study found modest evidence of reductions in out-of-pocket costs and improvements in health among adults entering Medicare after the Affordable Care Act. Insurance coverage and financial assistance should be preserved and enhanced to …

Novo Dives After Medicare Targets Wegovy For Price Cuts

Novo Nordisk (NVO) stock tumbled Friday after its weight-loss drug Wegovy and diabetes medicine Ozempic landed on Medicare's next list of drugs to face price negotiations. ↑ X NOW PLAYING The Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win …

MedRhythms earns Medicare win for stroke gait impairment treatment

The InTandem system in use. [Image courtesy of MedRhythms]MedRhythms announced that it received a final pricing determination from CMS for its InTandem rehabilitation system. InTandem delivers individualized, progressive rhythmic auditory stimulation (RAS) …